RCKT vs. QQQ

In the year-to-date period, RCKT achieves a -47.37% return, which is significantly lower than QQQ's 1.00% return. Over the past 10 years, RCKT has underperformed QQQ with an annualized return of -11.82%, while QQQ has yielded a comparatively higher 17.72% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Rocket Pharmaceuticals, Inc. (RCKT) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current RCKT Sharpe Ratio is -1.04, which is lower than the QQQ Sharpe Ratio of 0.67. The chart below compares the historical Sharpe Ratios of RCKT and QQQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

RCKT has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.58%.

The maximum RCKT drawdown since its inception was -94.90%, which is greater than QQQ's maximum drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for RCKT and QQQ. For additional features, visit the drawdowns tool.

Rocket Pharmaceuticals, Inc. (RCKT) has a higher volatility of 33.28% compared to Invesco QQQ (QQQ) at 7.54%. This indicates that RCKT's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.